Cefazolin (Perioperative Burns)
Brand names: Kefzol
Cefazolin is a first-generation intravenous cephalosporin used for surgical antibiotic prophylaxis around burns operations such as excision and grafting.
Adult dose
Dose adjustments
Adults with renal impairment may need a lower dose; this lower dose may be guided by determining blood levels, or if that is not possible the dosage can be established from creatinine clearance. SPC maintenance schedule: creatinine clearance 55 mL/min or more (serum creatinine 1.5 mg/100 mL or less) - normal dose and normal dosing interval; 35-54 mL/min (1.6-3.0 mg/100 mL) - normal dose every 8 hours; 11-34 mL/min (3.1-4.5 mg/100 mL) - half of the normal dose every 12 hours; 10 mL/min or less (4.6 mg/100 mL or more) - half of the normal dose every 18-24 hours. In haemodialysis patients the treatment schedule depends on the dialysis conditions. Although cefazolin rarely causes renal dysfunction, renal function should be monitored, especially in severely ill patients receiving maximum doses and in patients receiving other potentially nephrotoxic agents.
Dose auto-extracted from UK Summary of Product Characteristics (SPC) via the eMC; US FDA prescribing information (openFDA / DailyMed) — cross-check; US labelling may differ from UK — not yet clinician-verified. Always confirm against the product SmPC and your local formulary before prescribing.
Contraindications
- Hypersensitivity to the active substance
- History of severe hypersensitivity (e.g. anaphylactic reaction) to other beta-lactam antibiotics (penicillins, monobactams and carbapenems)
- Contraindications to lidocaine must be excluded before intramuscular injection of cefazolin when lidocaine solution is used as a solvent; cefazolin solutions containing lidocaine must never be administered intravenously
Side effects
- Common: oral candidiasis; genital candidiasis and vaginitis
- Gastrointestinal: nausea, vomiting, diarrhoea, anorexia; pseudomembranous colitis, which can be life-threatening and requires immediate cessation of cefazolin and appropriate therapy
- Hypersensitivity: rash, erythema, erythema multiforme, urticaria, angioedema; anaphylactic shock; rarely toxic epidermal necrolysis and Stevens-Johnson syndrome; Kounis syndrome (allergic coronary vasospasm potentially leading to myocardial infarction) has been reported
- Blood: leukopenia, granulocytopenia, neutropenia, thrombocytopenia, eosinophilia and other count changes - rare and reversible; coagulation disorders with subsequent bleeding
- Hepatobiliary: transient elevation of AST, ALT, alkaline phosphatase, gamma-GT, bilirubin and/or LDH; transient hepatitis and transient cholestatic jaundice
- Renal: nephrotoxicity, interstitial nephritis, proteinuria and transient elevation of blood urea nitrogen, usually in patients concomitantly treated with other potentially nephrotoxic agents; seizures have occurred in patients with renal dysfunction treated with inappropriately high doses
Interactions
- Section 4.5 of the UK SPC was not retrieved in this bundle - verify the full interaction section
- Potentially nephrotoxic agents such as aminoglycosides or potent diuretics (e.g. furosemide) given concomitantly - monitor renal function, especially in severely ill patients receiving maximum doses (SPC section 4.4)
- Probenecid may decrease renal tubular secretion of cephalosporins when used concurrently, resulting in increased and more prolonged cephalosporin blood levels (US labelling)
- Laboratory tests: a false positive reaction for glucose in the urine may occur with Benedict's solution, Fehling's solution or CLINITEST tablets, but not with enzyme-based tests; positive direct and indirect antiglobulin (Coombs) tests have occurred, including in neonates whose mothers received cephalosporins before delivery (US labelling)
- Antiperistaltic agents are contraindicated if antibiotic-associated pseudomembranous colitis is suspected (SPC section 4.4)
Clinical monograph
How it works
It binds penicillin-binding proteins to inhibit bacterial cell-wall peptidoglycan synthesis, giving reliable activity against staphylococci and streptococci that cause surgical-site infection.
Prescribing in practice
- Avoid in patients with a history of severe or immediate hypersensitivity to penicillins or cephalosporins, and use caution with any prior beta-lactam allergy.
- For prophylaxis it should be given so that adequate tissue concentrations are present at incision, with intra-operative re-dosing for prolonged procedures or major blood loss.
- Burns patients have altered, often increased, drug clearance and a large volume of distribution, so standard prophylactic exposure may be inadequate.
Monitoring
Monitor for hypersensitivity reactions and for surgical-site infection in the postoperative period.
Counselling the patient
- This antibiotic is given to lower the chance of wound infection around your operation.
- Tell the team about any previous reaction to penicillin or cephalosporin antibiotics.
Evidence & guidelines
Cefazolin is a guideline-recommended agent for surgical prophylaxis against skin-flora organisms across many procedure types.
Reference: NICE NG125; ASHP antimicrobial prophylaxis guidelines; Drug verified in RxNorm (NLM); confirm dosing against the manufacturer SPC (eMC). Verify against your local formulary and current prescribing references before prescribing. The structured dose values shown have been reviewed by a clinician. Monograph status: clinician-reviewed (2026-07-04).
Related
Curated clinical cross-links plus same-class fallbacks.
- ASA Physical Status Classification · Pre-operative Risk
- Parkland Formula for Burns Fluid Resuscitation · Burns
- POSSUM Score for Surgical Morbidity and Mortality · Perioperative Risk
- SORT (Surgical Outcome Risk Tool) · Perioperative Risk
- Revised Cardiac Risk Index (RCRI / Lee Index) · Perioperative Risk
- ASA Physical Status Classification · Perioperative Risk